Meeting
2012 Breast Cancer Symposium
Comparison of immunohistochemistry (IHC) and quantitative RT-PCR: ER, PR, and HER2 receptor status.
Authors
Cindy Christopherson
Celera Corporation
Cindy Christopherson , Monica Chang , David Eberhard , John Sninsky , Steven Anderson , Alice Wang , Shirley Kwok , Benjamin Calhoun
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A
Track
Risk Assessment, Prevention, Detection, and Screening
Sub Track
High Risk
Citation
J Clin Oncol 30, 2012 (suppl 27; abstr 47)
DOI
10.1200/jco.2012.30.27_suppl.47
Abstract #
47
Poster Bd #
D8
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Breast cancer ER, PR, and HER2 expression variance by germline cancer predisposition genes.
First Author: Grace Wei
Poster
2015 ASCO Annual Meeting
Variations in measured ER, PR, and HER2 status in synchronous and asynchronous paired breast cancer (BC) tumors.
First Author: Clayton Yates
Poster
2014 ASCO Annual Meeting
An estimation model for Oncotype DX recurrence score using routine histopathologic variables.
First Author: Hyunseok Kim
Poster
2024 ASCO Breakthrough
Characterization of estrogen receptor mutant breast cancer in 3D cell culture.
First Author: Olivia Mayer